Remove Clinic Remove Individual Remove Utilities Remove Vaccination
article thumbnail

Vaccine Uptake Strategies & Ethical Considerations- Part II

Integrated Care News by CFHA

Vaccine hesitancy is the delay in accepting or refusing vaccination despite the availability of vaccination services. It falls on a spectrum of vaccine attitudes and intentions, from those who recognize the importance of vaccines and accept all vaccines on one end of the spectrum to those who refuse all vaccines.

article thumbnail

Episode 236: ARM Episode 16 – Live from SGIM: Best of Antiracism Research at the Society of General Internal Medicine’s 2022 Annual Meeting

The Clinical Problem Solvers

Dr. Valtis is a 4th year Med-Peds Resident at Brigham & Women’s Hospital and Boston Children’s Hospital, and his research focuses on race and the utilization of security responses in the inpatient hospital setting. Yannis Valtis, Ebi Okah, and Carine Davila, about research in their respective fields.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dissemination pilot of a culturally-tailored HPV educational website for Hmong adolescents and parents in clinics and schools [Community based participatory research]

Annals of Family Medicine

Context: Our community-based participatory research (CBPR) team previously developed and piloted a culturally- and linguistically-tailored human papillomavirus (HPV) eHealth website ( [link] ) for Hmong adolescents and their parents that aimed to address low levels of HPV vaccine completion in this population.

Education 130
article thumbnail

CMS Publishes Grab Bag of Proposed Changes to the Medicaid Drug Rebate Program

FDA Law Blog

For 10 high-cost single source covered outpatient drugs selected annually by CMS, manufacturers would be required to respond to a so-called “price verification survey” by providing not only clinical and utilization information about the drug, but also costs of production, distribution, research, and marketing; revenue and profit; and ex-U.S.

article thumbnail

STATEMENT RELEASE: FDA Task Force Statement on President Trump’s First 100 Days in Office

Doctors for America

Meaningful Clinical Experience: We were pleased to see President Trump appoint an individual with essential clinical and research experience to serve as the next FDA Commissioner. We hope that Commissioner Makary will utilize his experience to help ensure FDA puts patients over politics throughout his tenure.